Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion.

Tytuł:
β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion.
Autorzy:
Zhang Y; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Li M; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Li L; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Qian G; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Wang Y; Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
Chen Z; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Liu J; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Fang C; Department of Vascular Surgery, Zhongshan Hospital Affiliated to Fudan University, Institute of Vascular Surgery, Fudan University, Shanghai, 200032, China.
Huang F; Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Guo D; Department of Vascular Surgery, Zhongshan Hospital Affiliated to Fudan University, Institute of Vascular Surgery, Fudan University, Shanghai, 200032, China.
Zou Q; Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
Chu Y; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China.
Yan D; Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, 200032, China. .
Źródło:
Nature communications [Nat Commun] 2020 Nov 26; Vol. 11 (1), pp. 6000. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Carvedilol/*pharmacology
Immune Evasion/*immunology
Membrane Proteins/*metabolism
Nucleotidyltransferases/*metabolism
Virus Diseases/*immunology
beta-Arrestin 2/*metabolism
Animals ; Carvedilol/therapeutic use ; Disease Models, Animal ; Drug Repositioning ; HEK293 Cells ; Herpesvirus 1, Human/immunology ; Humans ; Immune Evasion/drug effects ; Interferon-beta/metabolism ; Macrophages, Peritoneal/immunology ; Macrophages, Peritoneal/metabolism ; Male ; Mice ; Primary Cell Culture ; Proteolysis/drug effects ; RAW 264.7 Cells ; RNA-Seq ; Sendai virus/immunology ; Signal Transduction/drug effects ; Signal Transduction/immunology ; Vesiculovirus/immunology ; Virus Diseases/drug therapy ; Virus Diseases/virology ; beta-Arrestin 2/agonists ; beta-Arrestin 2/genetics
References:
Cell Rep. 2019 Mar 26;26(13):3798. (PMID: 30917330)
Nature. 2013 Jun 20;498(7454):332-7. (PMID: 23722159)
Cell. 2005 Sep 9;122(5):669-82. (PMID: 16125763)
J Cell Sci. 2007 Jan 15;120(Pt 2):213-8. (PMID: 17215450)
Annu Rev Immunol. 2014;32:461-88. (PMID: 24655297)
J Clin Invest. 2003 Aug;112(4):566-74. (PMID: 12925697)
Nat Chem Biol. 2018 Jan;14(1):58-64. (PMID: 29155428)
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11946-11955. (PMID: 31142647)
Nature. 2018 Nov;563(7729):131-136. (PMID: 30356214)
Science. 2018 Aug 17;361(6403):704-709. (PMID: 29976794)
Immunity. 2016 Sep 20;45(3):555-569. (PMID: 27637147)
Nat Immunol. 2006 Feb;7(2):139-47. (PMID: 16378096)
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6650-5. (PMID: 19363159)
Science. 2004 Dec 24;306(5705):2257-60. (PMID: 15618519)
Cell. 2019 Mar 7;176(6):1432-1446.e11. (PMID: 30827685)
Cell. 2010 Mar 19;140(6):805-20. (PMID: 20303872)
Science. 2004 Mar 5;303(5663):1526-9. (PMID: 14976262)
Nat Commun. 2018 Mar 7;9(1):976. (PMID: 29515120)
PLoS Pathog. 2017 Mar 8;13(3):e1006264. (PMID: 28273161)
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8. (PMID: 14982987)
Nat Commun. 2019 Feb 14;10(1):746. (PMID: 30765691)
Nature. 2001 Oct 18;413(6857):732-8. (PMID: 11607032)
Nature. 2017 Sep 21;549(7672):394-398. (PMID: 28902841)
N Engl J Med. 2020 Mar 5;382(10):929-936. (PMID: 32004427)
Science. 2003 Sep 5;301(5638):1394-7. (PMID: 12958365)
Eur Rev Med Pharmacol Sci. 2013;17(15):2103-10. (PMID: 23884833)
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14555-60. (PMID: 18787115)
Nat Commun. 2019 Jul 3;10(1):2936. (PMID: 31270323)
J Immunol. 2017 Sep 1;199(5):1856-1864. (PMID: 28747347)
Cell Death Differ. 2018 Nov;25(11):2037-2049. (PMID: 29786071)
J Neuroinflammation. 2018 Apr 10;15(1):102. (PMID: 29636059)
J Cell Sci. 2002 Feb 1;115(Pt 3):455-65. (PMID: 11861753)
Science. 2003 Sep 5;301(5638):1391-4. (PMID: 12958364)
Lancet. 2020 Feb 1;395(10221):311. (PMID: 31986259)
Science. 2013 Feb 15;339(6121):786-91. (PMID: 23258413)
Science. 2013 Feb 15;339(6121):826-30. (PMID: 23258412)
Cell. 2019 Mar 7;176(6):1447-1460.e14. (PMID: 30799039)
Nature. 2006 May 4;441(7089):101-5. (PMID: 16625202)
Science. 2013 Sep 20;341(6152):1390-4. (PMID: 23989956)
Nature. 2008 Oct 2;455(7213):674-8. (PMID: 18724357)
Mol Cell. 2004 May 7;14(3):303-17. (PMID: 15125834)
Cell Res. 2019 Jan;29(1):67-79. (PMID: 30410068)
Nat Immunol. 2020 Jan;21(1):17-29. (PMID: 31819255)
Nature. 2019 Mar;567(7748):394-398. (PMID: 30842653)
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. (PMID: 17925438)
N Engl J Med. 2020 Mar 5;382(10):970-971. (PMID: 32003551)
Glia. 2012 Sep;60(9):1366-77. (PMID: 22638989)
Substance Nomenclature:
0 (Arrb2 protein, mouse)
0 (Membrane Proteins)
0 (Sting1 protein, mouse)
0 (beta-Arrestin 2)
0K47UL67F2 (Carvedilol)
77238-31-4 (Interferon-beta)
EC 2.7.7.- (Nucleotidyltransferases)
EC 2.7.7.- (cGAS protein, mouse)
Entry Date(s):
Date Created: 20201127 Date Completed: 20201211 Latest Revision: 20201214
Update Code:
20240105
PubMed Central ID:
PMC7691508
DOI:
10.1038/s41467-020-19849-9
PMID:
33243993
Czasopismo naukowe
Virus infection may induce excessive interferon (IFN) responses that can lead to host tissue injury or even death. β-arrestin 2 regulates multiple cellular events through the G protein-coupled receptor (GPCR) signaling pathways. Here we demonstrate that β-arrestin 2 also promotes virus-induced production of IFN-β and clearance of viruses in macrophages. β-arrestin 2 interacts with cyclic GMP-AMP synthase (cGAS) and increases the binding of dsDNA to cGAS to enhance cyclic GMP-AMP (cGAMP) production and the downstream stimulator of interferon genes (STING) and innate immune responses. Mechanistically, deacetylation of β-arrestin 2 at Lys171 facilitates the activation of the cGAS-STING signaling and the production of IFN-β. In vitro, viral infection induces the degradation of β-arrestin 2 to facilitate immune evasion, while a β-blocker, carvedilol, rescues β-arrestin 2 expression to maintain the antiviral immune response. Our results thus identify a viral immune-evasion pathway via the degradation of β-arrestin 2, and also hint that carvedilol, approved for treating heart failure, can potentially be repurposed as an antiviral drug candidate.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies